Updated 7/13 to include the deal’s financial details. Gerresheimer plans to acquire Swiss medical technology company Sensile Medical and its array of liquid drug delivery devices. The buyout is a perfect fit in Gerresheimer’s portfolio, the company explained, since it will boost Gerresheimer’s drug delivery offerings and add new digital and electronic capabilities into the mix. […]
Featured
Cingulate raises $7.5m for controlled-release ADHD therapy
Cingulate Therapeutics said today that it landed a $7.5 million investment to help fund the development of its controlled-release ADHD drugs. The Kansas City-based company is working on a set of therapies that utilize its ‘Precision Time Release’ drug-delivery platform. Cingulate’s CEO, Shane Schaffer, told Drug Delivery Business News that his company set out to create an ADHD therapy that […]
Medtronic touts one-year data from insulin pump study
Medtronic (NYSE:MDT) and UnitedHealthcare (NYSE:UNH) today touted first-year results from a 6,000-person analysis designed to compare hospital admission rates between people with diabetes using insulin pumps and people controlling their diabetes with multiple daily injections of insulin. The study included people using Medtronic’s MiniMed 630G system, as well as previous iterations of the medtech giant’s insulin pumps. […]
Senseonics inks diabetes management deal with Glooko
Senseonics (NYSE:SENS) said today that it inked a global deal to integrate its Eversense continuous glucose monitoring system with Glooko‘s diabetes data management tech. Users will be able to sync data from their Eversense CGM directly into Glooko’s platform and view historical glucose trends, as well as receive real-time readings from their Eversense mobile app, according […]
Medtronic warns on connectivity issue with Guardian Connect app
Medtronic (NYSE:MDT) this month issued a letter to physicians warning them of a potential connectivity issue with the Guardian Connect mobile app. The medtech giant warned that people using the Guardian Connect system to keep track of their blood sugar levels should update to the latest version of the mobile app as soon as possible. Medtronic […]
Lifecare goes public to support implantable glucose meter
Norwegian life-sciences group Lifecare AS plans to begin trading today on the Merkur Market under the ticker symbol ‘LIFE-ME’. The company is developing an implantable glucose sensor designed for people living with diabetes. “People with diabetes must watch closely their glucose levels to get the right amount of insulin at the right time. Diabetics deserve a modern […]
Mylan launches generic drug-delivery patch for dementia patients
Mylan (NSDQ:MYL) announced today the U.S. launch of its rivastigmine transdermal drug-delivery patch, a generic version of Novartis‘ (NYSE:NVS) Exelon therapy. The company’s rivastigmine therapy is indicated for the treatment of dementia associated with Alzheimer’s disease and Parkinson’s disease. For the 12 months ending May 31, 2018, rivastigmine transdermal systems brought in $248 million in sales […]
Companion Medical wins FDA nod for Android version of smart pen app
Companion Medical said today that it won FDA clearance for the Android version of its InPen app. The company’s InPen system consists of a smart insulin injection pen that connects with an integrated diabetes management app. Companion Medical expects to release the app for Android users by the fourth quarter of this year. “We are […]
KemPharm touts efficacy data for pediatric ADHD therapy
KemPharm (NSDQ:KMPH) touted top-line data from a pivotal efficacy and safety trial of its KP415 pediatric ADHD product. The company reported that KP415, which consists of serdexmethylphenidate and d-methylphenidate, met the primary efficacy endpoint in people with attention-deficit/hyperactivity disorder between the ages of 6 and 12 years. KemPharm’s KP415 capsule makes use of d-MPH hydrochloride as […]
Vaccine maker PaxVax tackles the unmet need posed by chikungunya virus
Transmitted by the same mosquitoes that spread Zika virus and dengue fever, the chikungunya virus is named for an African word meaning “to become contorted.” People infected with the alphavirus are afflicted with lasting joint pain that causes their backs to hunch over, according to the World Health Organization. The virus, which has cropped up […]